TrialThe Lancet. Digital health2024

A prognostic and predictive computational pathology immune signature for ductal carcinoma in situ: retrospective results from a cohort within the UK/ANZ DCIS trial.

Haojia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.